SCHEDULE: RTW Corrects Compass Therapeutics Share Ownership

Sentiment:

Schedule 13G Amendment


RTW Investments and Roderick Wong filed an amended Schedule 13G to correct an administrative error, confirming they hold no shares in Compass Therapeutics, Inc.

Summary

  • RTW Investments, LP and Roderick Wong filed Amendment No. 1 to Schedule 13G for Compass Therapeutics, Inc.
  • The amendment corrects an administrative error from an earlier filing, which inadvertently stated ownership of Compass Therapeutics, Inc. shares.
  • As of June 30, 2025, the Reporting Persons (RTW Investments, LP and Roderick Wong) did not own any shares of Compass Therapeutics, Inc.
  • The aggregate amount beneficially owned by each Reporting Person is 0.00, representing 0.0% of the class of Ordinary Shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this filing is purely administrative, correcting an error and clarifying beneficial ownership to 0%. It has no direct positive or negative implications for the company's operations or financial performance.

Positives

  • The filing provides clarity and corrects the public record regarding share ownership, ensuring accurate disclosure.
  • It confirms that RTW Investments, LP and Roderick Wong do not hold any shares in Compass Therapeutics, Inc., removing any potential misinterpretation of their stake.

Negatives

  • An initial administrative error led to the inadvertent filing of incorrect share ownership information.

Risks

  • The risk of misrepresentation or misunderstanding regarding RTW Investments' and Roderick Wong's stake in Compass Therapeutics, Inc. due to the initial erroneous filing has been mitigated by this amendment.

Future Outlook

NA

Management Comments

  • Roderick Wong, M.D., Managing Partner of RTW Investments, LP, certified that the information set forth in the statement is true, complete, and correct to the best of his knowledge and belief.

Industry Context

This administrative filing is specific to a correction of share ownership and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: Provides accurate information regarding the beneficial ownership of RTW Investments and Roderick Wong, clarifying that they hold no shares, which may prevent misinterpretation of their stake.

Key Dates

DateDescription
06/30/2025Date of event which required filing of this statement, confirming no shares were owned by Reporting Persons.
08/14/2025Date of signature for the Amendment No. 1 to Schedule 13G.

Keywords

SEC filing, Schedule 13G, Amendment, RTW Investments, Roderick Wong, Compass Therapeutics, Share ownership, Administrative error, Disclosure

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.